Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environmentsPhilippa R Kennedy, Martin Felices, Upasana Sunil Arvindam et al.|Science Advances|2024Cited by 45
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Martin Felices, Madison Shackelford et al.|Cancer Immunology Research|2024Cited by 9
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiencyJacob A. Myers, Jeffrey S. Miller, Rih‐Sheng Huang et al.|Blood|2025Cited by 4
Figure S1 from A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Martin Felices, Nicholas A. Zorko et al.|Unknown|2025Cited by 0